[A case of long-term survival following combined modality therapy for peritoneal disseminated recurrence of duodenal cancer].

Akira Kabashima, Kensuke Kudo, Toshihiko Nakamura, Mizuki Ninomiya, Takayuki Hamatsu, Hirofumi Hasegawa, Chie Ushijima, Masayuki Kitamura

Research output: Contribution to journalArticle

Abstract

A 65-year-old man was diagnosed with primary duodenal cancer and he underwent pancreaticoduodenectomy in June 2006. S-1 was administered as the postoperative adjuvant chemotherapy. A peritoneal disseminated recurrence was diagnosed together with a right reniportal node and right hydronephrosis in February 2007. A ureteral stent was inserted. DOC +S-1 combination therapy was administered from March 2007. Following progression of the recurrence, CDDP+S-1 combination therapy was administered from August 2007. Temporal diminution of the recurrence was achieved with radiotherapy from May to June 2009. Following re-progression of the recurrence, biweekly CPT-11 therapy was administered from February 2010. Weekly PTX therapy was administered from January 2011. The patient died due to progression of the recurrence in June 2011, 5 years after the operation. Our patient maintained a good quality of life and achieved long-term survival by combined modality therapy for peritoneal disseminated recurrence of duodenal cancer.

Original languageEnglish
Pages (from-to)1969-1971
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume39
Issue number12
Publication statusPublished - Jan 1 2012

Fingerprint

Duodenal Neoplasms
Combined Modality Therapy
Recurrence
Survival
irinotecan
Pancreaticoduodenectomy
Hydronephrosis
Therapeutics
Adjuvant Chemotherapy
Stents
Radiotherapy
Quality of Life

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kabashima, A., Kudo, K., Nakamura, T., Ninomiya, M., Hamatsu, T., Hasegawa, H., ... Kitamura, M. (2012). [A case of long-term survival following combined modality therapy for peritoneal disseminated recurrence of duodenal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 39(12), 1969-1971.

[A case of long-term survival following combined modality therapy for peritoneal disseminated recurrence of duodenal cancer]. / Kabashima, Akira; Kudo, Kensuke; Nakamura, Toshihiko; Ninomiya, Mizuki; Hamatsu, Takayuki; Hasegawa, Hirofumi; Ushijima, Chie; Kitamura, Masayuki.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 39, No. 12, 01.01.2012, p. 1969-1971.

Research output: Contribution to journalArticle

Kabashima, A, Kudo, K, Nakamura, T, Ninomiya, M, Hamatsu, T, Hasegawa, H, Ushijima, C & Kitamura, M 2012, '[A case of long-term survival following combined modality therapy for peritoneal disseminated recurrence of duodenal cancer].', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 39, no. 12, pp. 1969-1971.
Kabashima, Akira ; Kudo, Kensuke ; Nakamura, Toshihiko ; Ninomiya, Mizuki ; Hamatsu, Takayuki ; Hasegawa, Hirofumi ; Ushijima, Chie ; Kitamura, Masayuki. / [A case of long-term survival following combined modality therapy for peritoneal disseminated recurrence of duodenal cancer]. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2012 ; Vol. 39, No. 12. pp. 1969-1971.
@article{801d0dd4f6be4175a85b7fc8e5434337,
title = "[A case of long-term survival following combined modality therapy for peritoneal disseminated recurrence of duodenal cancer].",
abstract = "A 65-year-old man was diagnosed with primary duodenal cancer and he underwent pancreaticoduodenectomy in June 2006. S-1 was administered as the postoperative adjuvant chemotherapy. A peritoneal disseminated recurrence was diagnosed together with a right reniportal node and right hydronephrosis in February 2007. A ureteral stent was inserted. DOC +S-1 combination therapy was administered from March 2007. Following progression of the recurrence, CDDP+S-1 combination therapy was administered from August 2007. Temporal diminution of the recurrence was achieved with radiotherapy from May to June 2009. Following re-progression of the recurrence, biweekly CPT-11 therapy was administered from February 2010. Weekly PTX therapy was administered from January 2011. The patient died due to progression of the recurrence in June 2011, 5 years after the operation. Our patient maintained a good quality of life and achieved long-term survival by combined modality therapy for peritoneal disseminated recurrence of duodenal cancer.",
author = "Akira Kabashima and Kensuke Kudo and Toshihiko Nakamura and Mizuki Ninomiya and Takayuki Hamatsu and Hirofumi Hasegawa and Chie Ushijima and Masayuki Kitamura",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "39",
pages = "1969--1971",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - [A case of long-term survival following combined modality therapy for peritoneal disseminated recurrence of duodenal cancer].

AU - Kabashima, Akira

AU - Kudo, Kensuke

AU - Nakamura, Toshihiko

AU - Ninomiya, Mizuki

AU - Hamatsu, Takayuki

AU - Hasegawa, Hirofumi

AU - Ushijima, Chie

AU - Kitamura, Masayuki

PY - 2012/1/1

Y1 - 2012/1/1

N2 - A 65-year-old man was diagnosed with primary duodenal cancer and he underwent pancreaticoduodenectomy in June 2006. S-1 was administered as the postoperative adjuvant chemotherapy. A peritoneal disseminated recurrence was diagnosed together with a right reniportal node and right hydronephrosis in February 2007. A ureteral stent was inserted. DOC +S-1 combination therapy was administered from March 2007. Following progression of the recurrence, CDDP+S-1 combination therapy was administered from August 2007. Temporal diminution of the recurrence was achieved with radiotherapy from May to June 2009. Following re-progression of the recurrence, biweekly CPT-11 therapy was administered from February 2010. Weekly PTX therapy was administered from January 2011. The patient died due to progression of the recurrence in June 2011, 5 years after the operation. Our patient maintained a good quality of life and achieved long-term survival by combined modality therapy for peritoneal disseminated recurrence of duodenal cancer.

AB - A 65-year-old man was diagnosed with primary duodenal cancer and he underwent pancreaticoduodenectomy in June 2006. S-1 was administered as the postoperative adjuvant chemotherapy. A peritoneal disseminated recurrence was diagnosed together with a right reniportal node and right hydronephrosis in February 2007. A ureteral stent was inserted. DOC +S-1 combination therapy was administered from March 2007. Following progression of the recurrence, CDDP+S-1 combination therapy was administered from August 2007. Temporal diminution of the recurrence was achieved with radiotherapy from May to June 2009. Following re-progression of the recurrence, biweekly CPT-11 therapy was administered from February 2010. Weekly PTX therapy was administered from January 2011. The patient died due to progression of the recurrence in June 2011, 5 years after the operation. Our patient maintained a good quality of life and achieved long-term survival by combined modality therapy for peritoneal disseminated recurrence of duodenal cancer.

UR - http://www.scopus.com/inward/record.url?scp=84875874814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875874814&partnerID=8YFLogxK

M3 - Article

C2 - 23267946

AN - SCOPUS:84875874814

VL - 39

SP - 1969

EP - 1971

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -